Alpha 2.0
Login Register
» Authors » Paul Bresser

Paul Bresser

Explore the profile of Paul Bresser including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 103
Citations 2247
Followers 0
Related Specialties
Pulmonary Medicine
Cardiology & Vascular Diseases
General Surgery
Top 10 Co-Authors
Tom van der Poll
Jaap J Kloek
Herre J Reesink
Jaring S van der Zee
Sulaiman Surie
Mart N van der Plas
Marcus J Schultz
Rene Lutter
Berto J Bouma
Alex F de Vos
Published In
Crit Care Med
Ned Tijdschr Geneeskd
J Thorac Cardiovasc Surg
Ann Thorac Surg
Am J Respir Crit Care Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Predominance of M2 macrophages in organized thrombi in chronic thromboembolic pulmonary hypertension patients
Koudstaal T, den Bosch T, Bergen I, Lila K, Bresser P, Bogaard H, et al.
Eur J Immunol . 2024 Apr; 54(6):e2350670. PMID: 38593342
Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating disease characterized by thrombotic occlusion of pulmonary arteries and vasculopathy, leading to increased pulmonary vascular resistance and progressive right-sided heart failure. Thrombotic...
2.
Organ involvement in newly diagnosed sarcoidosis patients in the Netherlands: The first large European multicentre prospective study
Van Woensel J, Koopman B, Schiefer M, van Kan C, Janssen M, Ramiro S, et al.
Respir Med . 2024 Apr; 226:107608. PMID: 38582302
Background: Clinical presentation and prevalence of organ involvement is highly variable in sarcoidosis and depends on ethnic, genetic and geographical factors. These data are not extensively studied in a Dutch...
3.
An observational study ascertaining the prevalence of bullae and blebs in young, healthy adults and its possible implications for scuba diving
Bresser M, Wingelaar T, Van Weering J, Bresser P, van Hulst R
Front Physiol . 2024 Feb; 15:1349229. PMID: 38420621
Intrapulmonary air-filled cavities, e.g., bullae, blebs, and cysts, are believed to contribute topulmonary barotrauma (PBT) and arterial gas embolism (AGE) in divers. However, literature is unclear about the prevalence of...
4.
Two-year diffusion capacity trajectory in COVID-19 pneumonia survivors
de Roos M, Heijnen R, Dijkstra N, Brinkman K, Jonkman N, Bresser P
Chron Respir Dis . 2024 Feb; 21:14799731231222284. PMID: 38333995
Reduced diffusion capacity (DLCO) after COVID 19 pneumonia was reported in hospitalised patients after discharge. Here, we studied the restoration of DLCO over a 24 months period in COVID-19 pneumonia...
5.
Patients with CTEPH and mild hemodynamic severity of disease improve to a similar level of exercise capacity after pulmonary endarterectomy compared to patients with severe hemodynamic disease
van Kan C, Tramper J, Bresser P, Meijboom L, Symersky P, Winkelman J, et al.
Pulm Circ . 2024 Jan; 14(1):e12316. PMID: 38274560
The correlation between hemodynamics and degree of pulmonary vascular obstruction (PVO) is known to be poor in chronic thromboembolic pulmonary hypertension (CTEPH), which makes the selection of patients eligible for...
6.
Pulmonary function and Quality of Life in a prospective cohort of (non-) hospitalized COVID-19 pneumonia survivors up to six months
de Roos M, Siegerink S, Dijkstra N, Broekman B, Brinkman K, Jonkman N, et al.
Chron Respir Dis . 2022 Nov; 19:14799731221114271. PMID: 36367295
Objectives: A decrease of both diffusion capacity (DLCO) and Quality of Life (QoL) was reported after discharge in hospitalized COVID-19 pneumonia survivors. We studied three and 6 month outcomes in...
7.
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial
van den Berk I, Kanglie M, van Engelen T, Altenburg J, Annema J, Beenen L, et al.
Thorax . 2022 Jun; 78(5):515-522. PMID: 35688623
Background: Chest CT displays chest pathology better than chest X-ray (CXR). We evaluated the effects on health outcomes of replacing CXR by ultra-low-dose chest-CT (ULDCT) in the diagnostic work-up of...
8.
Evidence for a Role of CCR6+ T Cells in Chronic Thromboembolic Pulmonary Hypertension
van Uden D, Koudstaal T, van Hulst J, van den Bosch T, Vink M, Bergen I, et al.
Front Immunol . 2022 May; 13:861450. PMID: 35572511
Introduction: Previous studies have shown an increase of T cells and chemokines in vascular lesions of patients with chronic thromboembolic pulmonary hypertension (CTEPH). However, detailed characterization of these T cells...
9.
Vitamin D supplementation in chronic obstructive pulmonary disease patients with low serum vitamin D: a randomized controlled trial
Rafiq R, Aleva F, Schrumpf J, Daniels J, Bet P, Boersma W, et al.
Am J Clin Nutr . 2022 Apr; 116(2):491-499. PMID: 35383823
Background: Vitamin D deficiency is frequently found in patients with chronic obstructive pulmonary disease (COPD). Vitamin D has antimicrobial, anti-inflammatory, and immunomodulatory effects. Therefore, supplementation may prevent COPD exacerbations, particularly...
10.
Reduced baroreflex sensitivity and increased splenic activity in patients with severe obstructive sleep apnea
Kaiser Y, Dzobo K, Ravesloot M, Nurmohamed N, Collard D, Hoogeveen R, et al.
Atherosclerosis . 2022 Feb; 344:7-12. PMID: 35114557
Background And Aims: Severe obstructive sleep apnea (OSA) is associated with an increased risk of cardiovascular disease. Experimental evidence suggests that this risk may be mediated by chronic sympathetic hyperactivation...